View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
February 17, 2016

Samsung NeuroLogica and Mercy Life Flight Network launch new mobile stroke unit in Ohio, US

Samsung NeuroLogica and Mercy Life Flight Network have launched its new mobile stroke unit (MSU) in greater north western Ohio to cater to fast treatment requirements for patients suffering strokes.

MSU

Samsung NeuroLogica and Mercy Life Flight Network have launched its new mobile stroke unit (MSU) in greater north western Ohio to cater to fast treatment requirements for patients suffering strokes.

Free Report
img

What is the Global Healthcare and Pharma Market Q2 Outlook?

Given the background of high inflation, re-emerging supply chain issues, and the widespread macro-economic implications of the Ukraine conflict, the global pharmaceutical industry is facing an entirely new set of challenges following the turbulence of the COVID-19 pandemic. GlobalData’s World Markets Healthcare (WMH) service has released its latest Q2 forecast. This report incorporates the latest thinking on the opportunities and risks this new environment presents for pharma companies. However, the pharma sector is proving resilient, and we are projecting 4.4% global growth for the year ahead. Yet it remains that the current economic picture is inverting some baseline assumptions from previous quarterly forecasts and altering which markets we expect the key growth levers to derive from. Download our latest executive summary for a snapshot view of what our clients use to formulate winning strategies.
by GlobalData
Enter your details here to receive your free Report.

The vehicle, the fourth of its kind, was developed jointly by Stryker, Frazer and Samsung NeuroLogica, with a $1m grant from the Mercy Foundation.

Procured in partnership with the Lucas County Commissioners and the city of Toledo to address new stroke care protocols, the MSU comprises a critical care nurse, paramedic and CT technologist for immediate attention for patients.

Mercy Health MSU programme manager Julie Goins-Whitmore said: "The key to stroke care is determining what kind of stroke is occurring, whether it is haemorrhagic or ischemic.

"Performing the scan out in the field quickens the diagnostic process, which is critical to starting the right treatment as soon as possible.

"Performing the scan out in the field quickens the diagnostic process, which is critical to starting the right treatment as soon as possible."

"It is also a huge relief for patients and their families to have a much better idea of what is happening before the MSU even leaves their driveways."

The unit will be fitted with a CereTom mobile CT scanner, which is an eight-slice system to relay high-quality scans to specialists at the hospital in various patient locations enabling immediate treatment of the patient.

It features a rapid scan time, easy-to-use interface and immediate image viewing option and is suitable for use in a range of settings, including the MSU, ICU, NICU, and emergency department and in patient rooms.

Each year, strokes kill nearly 130,000 Americans, 87% of which accounts being ischemic, resulting to dysfunction of tissue.

The MSU equipped with CereTom is on display at the ongoing AHA / International Stroke Conference at the Los Angeles Convention Centre.

A CereTom equipped MSU was displayed in October 2015 at the American College of Emergency Physicians (ACEP) Scientific Assembly in Boston.


Image: Mercy Life Flight Network Mobile Stroke Unit. Photo: courtesy of by Samsung NeuroLogica.

Related Companies

Free Report
img

What is the Global Healthcare and Pharma Market Q2 Outlook?

Given the background of high inflation, re-emerging supply chain issues, and the widespread macro-economic implications of the Ukraine conflict, the global pharmaceutical industry is facing an entirely new set of challenges following the turbulence of the COVID-19 pandemic. GlobalData’s World Markets Healthcare (WMH) service has released its latest Q2 forecast. This report incorporates the latest thinking on the opportunities and risks this new environment presents for pharma companies. However, the pharma sector is proving resilient, and we are projecting 4.4% global growth for the year ahead. Yet it remains that the current economic picture is inverting some baseline assumptions from previous quarterly forecasts and altering which markets we expect the key growth levers to derive from. Download our latest executive summary for a snapshot view of what our clients use to formulate winning strategies.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management